Access to Medicine Foundation

NOW ONLINE: The 2024 Access to Medicine Index #ATMI24 provides an in-depth analysis of what the #pharma industry is doing to bridge the gap in #EquitableAccess. Despite incredible progress in #GlobalHealth, half of the global population still struggles to access the medicines and #healthcare they desperately need. The 2024 Access to Medicine Index shows an overall stagnation in pharmaceutical companies’ efforts to improve access to essential healthcare products across low- and middle-income countries #LMICs. While some modest progress has been made, the potential for improving access is still far from realised and the pace of change is slow. Watch Jayasree Iyer, the Foundation's CEO, as she shares the key findings from this ninth iteration of the Index and discusses how the industry has performed over the past two years. Read the 2024 Access to Medicine Index here ➡ https://lnkd.in/e5g_YHCm #AccesstoMedicine #AccesstoHealthcare #HealthEquity Foreign, Commonwealth and Development Office, Ministerie van Buitenlandse Zaken, Bill & Melinda Gates Foundation, The Helmsley Charitable Trust, Wellcome Trust, Stewart Investors, AXA Investment Managers, Mira M. Fricke, John Muchangi, Holger Alich, Lena Hunter, Sohini Das

It’s that time again… Tomorrow, the new episode of the P4P Podcast is released!🎙️ This week, Pensions for Purpose talks to Clare Wood, of Stewart Investors about Access to Medicine Foundation and how sustainable investors can support healthcare and align with SDG 3: 'Good Health and Well-being'. Here’s a snippet on maternal mortality and the global disparities in health access, like preventable cervical cancer deaths in India. Listen to the whole of episode 12, on 4 December; the podcast will be available on our website – Apple Podcasts, Spotify, Amazon Music (or wherever you get your podcasts). #GlobalHealthcare #AccesstoMedicines #PensionsforPurpose

In collaboration with AllianceBernstein, we are hosting an investor launch event for the 2024 Access to Medicine Index #ATMI24 this week in New York. The event will bring together investors and company representatives from around the globe to dive into insights from the latest Index and explore impactful ways to enhance #AccesstoMedicine in low- and middle-income countries #LMICs. Investors are crucial in steering #pharma companies toward sustainable practices that can make a real difference in #GlobalHealth. The Access to Medicine Index empowers them to identify opportunities for engagement, fostering sustainable growth and improved health outcomes in LMICs. Learn more about the event ➡ https://lnkd.in/ew2r-Cgc Are you an investor? Join our SDG3 Collaborative to drive impactful change for a healthier, more equitable world ➡ https://lnkd.in/eck3Fhti #ESG #ResponsibleInvesting #SustainableInvesting #ImpactInvesting #EquitableAccess #AccesstoHealthcare

In an article for The Guardian, Julia Kollewe covers the publication of the 2024 #AccesstoMedicine Index #ATMI24, spotlighting the challenges that stem from the #pharma industry's limited focus on addressing critical #healthcare needs in low- and middle-income countries #LMICs. She highlights the finding that only 43% of #ClinicalTrials take place in LMICs covered by the report, despite being home to 80% of the global population. Since companies typically focus their access planning in countries where they conduct trials, this leaves many patients in need behind. Kollewe quotes the Foundation's CEO, Jayasree Iyer: "Companies have very clearly said we will register and prioritise registration in countries where the trials are running, but if they don’t run the trials in more areas… then you’re never going to solve this health equity problem for all the innovative new products." Read the article ➡️ https://lnkd.in/eNGJU7tk #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth

80% of the total global disease burden of neglected tropical diseases #NTDs is faced by just 15 low- and middle-income countries #LMICs, contributing to an estimated 14.5 million disability-adjusted life years. Through long-term donation programmes, #pharma companies can provide access to NTD treatments for people who are unable to or have limited resources to pay for it. The 2024 #AccesstoMedicine Index #ATMI24 has identified five additional donation programmes targeting NTDs, bringing the total number to 19. What do these programmes look like? Read in the report ➡️ https://lnkd.in/e5g_YHCm #HealthEquity #EquitableAccess #AccesstoHealthcare #GlobalHealth

Has the #pharma industry advanced in achieving global #HealthEquity? The 2024 Access to Medicine Index #ATMI24 finds that while some modest progress has been made, the potential for improving access is still far from realised. The pace of change needs to be vastly accelerated to meet the growing unmet healthcare needs in low- and middle-income countries #LMICs. #EquitableAccess to medicines is more urgent than ever. Innovative treatments can improve #GlobalHealth – but only if they are accessible to all. Read the key findings from the 2024 #AccesstoMedicine Index ➡ https://lnkd.in/eDiSvXyQ #AccesstoHealthcare #InclusiveBusinessModels #IBMs #ClinicalTrials #CTs #VoluntaryLicensing #TechnologyTransfer #LocalAvailability #availability

Speaking about the #AccesstoMedicine Index as a changemaking tool, Dr Zainab Shinkafi-Bagudu, CEO at MEDICAID CANCER FOUNDATION and President-Elect of the Union for International Cancer Control (UICC) notes: "The Index that the Foundation works on is sort of a competition. It creates an environment whereby you want to do better and you want to do more. It’s a driver for #HealthEquity, it’s a driver for positive change in the therapeutic landscape and it’s a driver to save lives – bottom line." Watch the full #interview ➡ https://lnkd.in/ePf35XZy Read the 2024 Access to Medicine Index #ATMI24 ➡ https://lnkd.in/e5g_YHCm #EquitableAccess #AccesstoHealthcare #GlobalHealth #pharma #changemaking #impact

In her latest op-ed for the World Economic Forum, our CEO, Jayasree Iyer, writes about how #EquitableAccess to medicines isn't just a moral imperative but a strategic opportunity for sustainable returns. The 2024 #AccesstoMedicine Index #ATMI24 highlights how prioritising affordable and locally available medicines in low- and middle-income countries #LMICs can unlock new markets and drive innovation. With 80% of the global population living in LMICs, the demand for essential treatments, ranging from infectious diseases to non-communicable conditions like cancer and diabetes, is higher than ever. How can #pharma companies and #investors help transform #healthcare in underserved regions while driving sustainable growth? Read more in the op-ed ➡️ https://lnkd.in/ergMqG-M #HealthEquity #AccesstoHealthcare #GlobalHealth #ESG #ResponsibleInvestment #SustainableInvestment #ImpactInvesting #sustainability #impact

Congratulations Access to Medicine Foundation! We are excited to read the publication of the 2024 Access to Medicine Index https://ow.ly/4QaW50UfI2Y As investors, we see this as an important tool to help build a picture of areas where healthcare companies can continue improving and where investors can focus their engagements to drive better health and business outcomes, raising the bar for what affordable and accessible medicine means worldwide. In 2024 we entered a research partnership with the Access to Medicine Foundation, helping support an organisation we have long admired. Find out more https://ow.ly/iwlT50UfI2X

Non-communicable diseases #NCDs are the number one cause of death and disability worldwide, with three-quarters of these deaths occurring in low- and middle-income countries #LMICs. Through voluntary licensing, #pharma companies can improve access to vital NCD treatments in LMICs. The 2024 #AccesstoMedicine Index #ATMI24 finds that voluntary licensing continues to be a severely underutilised mechanism in NCDs. 26 of 27 licences analysed cover communicable diseases, such as HIV and hepatitis B and C. By engaging in more licensing agreements for NCDs, companies could facilitate access to innovative medicines that can improve quality of life and save lives globally. Read the 2024 Access to Medicine Index ➡ https://lnkd.in/e5g_YHCm #EquitableAccess #AccesstoHealthcare #HealthEquity #GlobalHealth